Company lists · Data refreshed September 2026
Top 24 Immunotherapy venture capital companies based in the United States
RevenueBase identified 663 immunotherapy venture capital companies headquartered in the United States as of September 2026 and tracks 22,711 professional contacts across them, including 11,948 with verified work emails and 10,598 with mobile numbers. Cambridge is the largest hub.
This list covers immunotherapy venture capital companies headquartered in the United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, how directly it supports the match, and when it was last checked. Data refreshed September 3, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 24 largest immunotherapy venture capital companies based in the United States
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | Kite PharmaIndirect evidence | 3,768 | |||
“At Kite, a Gilead Company, our singular focus is achieving cures with cell therapy.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 2 | 981 | ||||
“Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 3 | 799 | ||||
“Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 4 | 695 | ||||
“Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 5 | 632 | ||||
“Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 6 | 592 | ||||
“ImmunityBio, Inc.(formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 7 | ReplimuneIndirect evidence | 463 | |||
“Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 8 | 273 | ||||
Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 9 | 247 | ||||
“Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 10 | Vera Therapeutics, INCIndirect evidence | 222 | |||
Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 11 | Lyell ImmunopharmaIndirect evidence | 212 | |||
“Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 12 | Umoja BiopharmaIndirect evidence | 202 | |||
“Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 13 | 193 | ||||
“Atara Biotherapeutics Inc, is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 14 | Tscan TherapeuticsIndirect evidence | 190 | |||
“TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 15 | 152 | ||||
“Century Therapeutics is an innovative biotechnology company that is building an industry-leading, allogeneic, iPSC-derived cell therapy platform that integrates cutting-edge gene…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 16 | 152 | ||||
“CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 17 | 133 | ||||
“Precigen (Nasdaq: PGEN) is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 18 | 132 | ||||
“The Cancer Research Institute (CRI) is a nonprofit organization exclusively focused on advancing cancer immunotherapy through rigorous scientific research, global collaboration…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 19 | 129 | ||||
“IGI, Inc.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 20 | Trisalus Life SciencesPartial evidence | 125 | |||
“TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 21 | AlumisIndirect evidence | 124 | |||
“At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 22 | 124 | ||||
“A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 23 | 123 | ||||
“Atlas Venture is a leading biotech venture capital firm.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 24 | Rapt TherapeuticsIndirect evidence | 123 | |||
“RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
Showing 24 of 663 immunotherapy venture capital companies based in the United States
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 11,948 reachable decision-makers.
Free signup · no credit card
Immunotherapy venture capital companies based in the United States at a glance
As of Sep 3, 2026Companies by employee count
Verified emails by last verification
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and evidence rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in the United States whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
- What we exclude
- Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside United States are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and an evidence rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 11,948 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Immunotherapy venture capital companies by metro
- Immunotherapy venture capital companies in Cambridge50
- Immunotherapy venture capital companies in San Diego49
- Immunotherapy venture capital companies in Boston39
- Immunotherapy venture capital companies in New York29
- Immunotherapy venture capital companies in South San Francisco28
- Immunotherapy venture capital companies in San Francisco26
Frequently asked
How many immunotherapy venture capital companies are there based in the United States?
RevenueBase identified 663 immunotherapy venture capital companies headquartered in the United States as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Kite Pharma, headquartered in Frederick, tops this list with the largest team on record.
Which city has the most immunotherapy venture capital companies?
Cambridge leads with 50 headquartered companies, followed by San Diego (49) and Boston (39).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 11,948 verified decision-maker contacts tracked across these 663 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.
Ready to reach these companies? Verified emails and direct dials for all 663 immunotherapy venture capital companies based in the United States. Start with a free account, no credit card.
Get the full listRelated lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
- Immunotherapy venture capital companies based in San Francisco, United States
Browse the directory
Browse: Companies home · All United States lists · All Immunotherapy venture capital companies lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia